# Bioequivalence Study of Sumatriptan 100mg Tablets Under Fed Conditions

> **NCT00872274** · NA · COMPLETED · sponsor: **Ranbaxy Laboratories Limited** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** sumatriptan 100mg

## Key facts

- **NCT ID:** NCT00872274
- **Lead sponsor:** Ranbaxy Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2008-07
- **Final completion:** 2008-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2009-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00872274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00872274, "Bioequivalence Study of Sumatriptan 100mg Tablets Under Fed Conditions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00872274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*